Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Type 10 Soluble Adenylyl Cyclase Is Overexpressed in Prostate Carcinoma and Controls Proliferation of Prostate Cancer Cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 5, Pages 3126-3135
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2012-12-20
DOI
10.1074/jbc.m112.403279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble Adenylyl Cyclase Antibody Profile as a Diagnostic Adjunct in the Assessment of Pigmented Lesions
- (2011) Cynthia M. Magro ARCHIVES OF DERMATOLOGY
- Type 10 adenylyl cyclase mediates mitochondrial Bax translocation and apoptosis of adult rat cardiomyocytes under simulated ischaemia/reperfusion
- (2011) Avinash Appukuttan et al. CARDIOVASCULAR RESEARCH
- Knockdown of B-Raf impairs spindle formation and the mitotic checkpoint in human somatic cells
- (2011) Meghan Borysova et al. CELL CYCLE
- Targeting Continued Androgen Receptor Signaling in Prostate Cancer
- (2011) C. Massard et al. CLINICAL CANCER RESEARCH
- Intracellular cAMP signaling by soluble adenylyl cyclase
- (2011) Martin Tresguerres et al. KIDNEY INTERNATIONAL
- CCL21/CCR7 Promotes G2/M Phase Progression via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells
- (2011) Ying Xu et al. PLoS One
- 8-Chloro-Cyclic AMP and Protein Kinase A I-Selective Cyclic AMP Analogs Inhibit Cancer Cell Growth through Different Mechanisms
- (2011) Simona Lucchi et al. PLoS One
- Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1act/Tubulin Interaction Is an Important Determinant of Mitotic Stability in Cultured HT1080 Human Fibrosarcoma Cells
- (2010) J.-n. Cao et al. CANCER RESEARCH
- Exchange Protein Directly Activated by Cyclic AMP Increases Melanoma Cell Migration by a Ca2+-Dependent Mechanism
- (2010) E. Baljinnyam et al. CANCER RESEARCH
- Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor
- (2010) Dennis Merkle et al. CELLULAR SIGNALLING
- Soluble Adenylyl Cyclase Defines a Nuclear cAMP Microdomain in Keratinocyte Hyperproliferative Skin Diseases
- (2010) Jonathan H. Zippin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- PKA and Epac synergistically inhibit smooth muscle cell proliferation
- (2010) Richard C. Hewer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- EPAC proteins transduce diverse cellular actions of cAMP
- (2009) Gillian Borland et al. BRITISH JOURNAL OF PHARMACOLOGY
- Down-regulation of Rap1GAP via Promoter Hypermethylation Promotes Melanoma Cell Proliferation, Survival, and Migration
- (2009) H. Zheng et al. CANCER RESEARCH
- Cyclic AMP Produced inside Mitochondria Regulates Oxidative Phosphorylation
- (2009) Rebeca Acin-Perez et al. Cell Metabolism
- Soluble Adenylyl Cyclase Controls Mitochondria-dependent Apoptosis in Coronary Endothelial Cells
- (2009) Sanjeev Kumar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades
- (2009) Uma Kant Misra et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Sustained cyclic AMP production by parathyroid hormone receptor endocytosis
- (2009) Sébastien Ferrandon et al. Nature Chemical Biology
- Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
- (2009) Davide Calebiro et al. PLOS BIOLOGY
- Somatic ‘Soluble’ Adenylyl Cyclase Isoforms Are Unaffected in Sacytm1Lex/Sacytm1Lex ‘Knockout’ Mice
- (2008) Jeanne Farrell et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More